99% Savings - Buy Just @1 Rs X
Wergomet 0.2 Mg Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Post Delivery Bleeding.
Medical history of the patient along with age and gender determines the dosage of Wergomet 0.2 Mg Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Wergomet 0.2 Mg Injection are Headache, Abdominal Pain, Hypertension. Some other side effects of Wergomet 0.2 Mg Injection have been listed ahead. Such side effects of Wergomet 0.2 Mg Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Wergomet 0.2 Mg Injection has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Further, the section on Wergomet 0.2 Mg Injection related warnings talks about Wergomet 0.2 Mg Injection's effects on the liver, heart and kidney.
Wergomet 0.2 Mg Injection is contraindicated in people with pre-existing medical conditions like High Blood Pressure as it can result in adverse effects. Other contraindications of Wergomet 0.2 Mg Injection have been discussed in the sections ahead.
Drug reaction of Wergomet 0.2 Mg Injection with other medicines has been reported. See below for a complete list.
You should also be aware that Wergomet 0.2 Mg Injection is safe while driving, and is addiction.
Wergomet 0.2 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Wergomet 0.2 Mg Injection safe for pregnant women?
Side effects of Wergomet during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Wergomet 0.2 Mg Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Wergomet for breastfeeding women are not known.
What is the effect of Wergomet 0.2 Mg Injection on the Kidneys?
Wergomet rarely harms the kidneys.
What is the effect of Wergomet 0.2 Mg Injection on the Liver?
Wergomet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Wergomet 0.2 Mg Injection on the Heart?
Effects of Wergomet on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Wergomet 0.2 Mg Injection unless your doctor advises you to do so -
Is this Wergomet 0.2 Mg Injection habit forming or addictive?
Wergomet 0.2 Mg Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Wergomet 0.2 Mg Injection since it will not make you feel sleepy.
Is it safe?
Yes, but consume Wergomet 0.2 Mg Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Wergomet 0.2 Mg Injection cannot treat any kind of mental disorder.
Interaction between Food and Wergomet 0.2 Mg Injection
Due to the absence of research, it is difficult to say how Wergomet 0.2 Mg Injection and food will interact.
Interaction between Alcohol and Wergomet 0.2 Mg Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Wergomet 0.2 Mg Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839